Lyka Labs Q2 Results
- BSE: 500259
- NSE: LYKALABS
- ISIN: INE933A01014
- Sector: Biotechnology & Drugs
BSE
147
3.65 (2.55%)
3.65 (2.55%)Volume12.87 K
Updated: Mon 25 Nov, 2024 | 15:28:54
NSE
146.994.23 (2.96%)
4.23 (2.96%)Volume84.27 K
Updated: Mon 25 Nov, 2024 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹41.16 Cr.(36.66%)
- Operating Profit₹3.19 Cr.(63.46%)
- Profit After Tax₹2.10 Cr.(45.58%)
- Operating Margin7.75%(1358.28%)
Note: Comparison is on YoY basis
Quarterly - Lyka Labs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 41.16 | 22.88 | -% | 27.99 | -% |
| Selling/ General/ Admin Expenses Total | 8.35 | 5.94 | -% | 6.44 | -% |
| Depreciation/ Amortization | 1.76 | 3.47 | -% | 3.59 | -% |
| Other Operating Expenses Total | 9.91 | 4.79 | -% | 5.68 | -% |
| Total Operating Expense | 37.97 | 23.70 | -% | 27.84 | -% |
| Operating Income | 3.19 | -0.82 | -% | 0.15 | -% |
| Net Income Before Taxes | 2.67 | -1.80 | -% | -0.79 | -% |
| Net Income | 2.10 | -1.85 | -% | -0.49 | -% |
| Diluted Normalized EPS | 0.58 | -0.57 | -% | -0.07 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST